180 related articles for article (PubMed ID: 29801587)
1. An overview of mortality & predictors of small-cell and non-small cell lung cancer among Saudi patients.
Alghamdi HI; Alshehri AF; Farhat GN
J Epidemiol Glob Health; 2018 Mar; 7 Suppl 1(Suppl 1):S1-S6. PubMed ID: 29801587
[TBL] [Abstract][Full Text] [Related]
2. Effect of histological subtype and treatment modalities on T1-2 N0-1 small cell lung cancer: A population-based study.
Moon SW; Seo JH; Jeon HW; Moon MH
Thorac Cancer; 2019 May; 10(5):1229-1240. PubMed ID: 30993901
[TBL] [Abstract][Full Text] [Related]
3. Molecular genetics of small cell lung carcinoma.
Wistuba II; Gazdar AF; Minna JD
Semin Oncol; 2001 Apr; 28(2 Suppl 4):3-13. PubMed ID: 11479891
[TBL] [Abstract][Full Text] [Related]
4. Survival of patients with small cell lung cancer undergoing lung resection in England, 1998-2009.
Lüchtenborg M; Riaz SP; Lim E; Page R; Baldwin DR; Jakobsen E; Vedsted P; Lind M; Peake MD; Mellemgaard A; Spicer J; Lang-Lazdunski L; Møller H
Thorax; 2014 Mar; 69(3):269-73. PubMed ID: 24172710
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA expression distinguishes SCLC from NSCLC lung tumor cells and suggests a possible pathological relationship between SCLCs and NSCLCs.
Du L; Schageman JJ; Irnov ; Girard L; Hammond SM; Minna JD; Gazdar AF; Pertsemlidis A
J Exp Clin Cancer Res; 2010 Jun; 29(1):75. PubMed ID: 20624269
[TBL] [Abstract][Full Text] [Related]
6. Large-Cell Neuroendocrine Carcinoma of the Lung: A Population-Based Study.
Kinslow CJ; May MS; Saqi A; Shu CA; Chaudhary KR; Wang TJC; Cheng SK
Clin Lung Cancer; 2020 Mar; 21(2):e99-e113. PubMed ID: 31601526
[TBL] [Abstract][Full Text] [Related]
7. Delays during the diagnostic evaluation and treatment of lung cancer.
Chandra S; Mohan A; Guleria R; Singh V; Yadav P
Asian Pac J Cancer Prev; 2009; 10(3):453-6. PubMed ID: 19640190
[TBL] [Abstract][Full Text] [Related]
8. Hyperthermia induced HIF-1a expression of lung cancer through AKT and ERK signaling pathways.
Wan J; Wu W
J Exp Clin Cancer Res; 2016 Jul; 35(1):119. PubMed ID: 27456341
[TBL] [Abstract][Full Text] [Related]
9. A Japanese lung cancer registry study on demographics and treatment modalities in medically treated patients.
Sekine I; Shintani Y; Shukuya T; Takayama K; Inoue A; Okamoto I; Kiura K; Takahashi K; Dosaka-Akita H; Takiguchi Y; Miyaoka E; Okumura M; Yoshino I
Cancer Sci; 2020 May; 111(5):1685-1691. PubMed ID: 32103551
[TBL] [Abstract][Full Text] [Related]
10. The impact of reclassifying cancers of unspecified histology on international differences in survival for small cell and non-small cell lung cancer (ICBP SurvMark-2 project).
Morgan E; Arnold M; Rutherford MJ; Bardot A; Ferlay J; De P; Engholm G; Jackson C; Little A; Saint-Jacques N; Walsh P; Woods RR; O'Connell DL; Bray F; Parkin DM; Soerjomataram I
Int J Cancer; 2021 Sep; 149(5):1013-1020. PubMed ID: 33932300
[TBL] [Abstract][Full Text] [Related]
11. SUVmax during 18FDG-PET scanning in small cell lung cancer: similar information as in non-small cell lung cancer?
van der Leest C; Smit EF; Baas J; Versteijlen RJ; van Walree N; Hoogsteden HC; Aerts JG
Lung Cancer; 2012 Apr; 76(1):67-71. PubMed ID: 21996089
[TBL] [Abstract][Full Text] [Related]
12. The utility of p53 immunostaining of transbronchial biopsy specimens of lung cancer: p53 overexpression predicts poor prognosis and chemoresistance in advanced non-small cell lung cancer.
Kawasaki M; Nakanishi Y; Kuwano K; Yatsunami J; Takayama K; Hara N
Clin Cancer Res; 1997 Jul; 3(7):1195-200. PubMed ID: 9815799
[TBL] [Abstract][Full Text] [Related]
13. Surgery for small cell lung cancer: A Surveillance, Epidemiology, and End Results (SEER) Survey from 2010 to 2015.
Xu L; Zhang G; Song S; Zheng Z
Medicine (Baltimore); 2019 Oct; 98(40):e17214. PubMed ID: 31577711
[TBL] [Abstract][Full Text] [Related]
14. Incidence, survival comparison, and novel prognostic evaluation approaches for stage iii-iv pulmonary large cell neuroendocrine carcinoma and small cell lung cancer.
Huang L; Feng Y; Xie T; Zhu H; Tang L; Shi Y
BMC Cancer; 2023 Apr; 23(1):312. PubMed ID: 37020179
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors in lung cancer in a defined geographical area over two decades with a special emphasis on gender.
Svensson G; Ewers SB; Ohlsson O; Olsson H
Clin Respir J; 2013 Jan; 7(1):91-100. PubMed ID: 22380488
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of serum vascular endothelial growth factor and Angiopoietin-2 in patients with lung cancer.
Akın Kabalak P; Çiledağ A; Demir N; Çelik G; Yüksel C; Köycü G; Gökmen Öztuna D; Taner A; Kaya A; Kutlay H; Numanoğlu N; Savaş İ
Tuberk Toraks; 2015 Jun; 63(2):71-7. PubMed ID: 26167963
[TBL] [Abstract][Full Text] [Related]
17. Predictors of survival for younger patients less than 50 years of age with non-small cell lung cancer (NSCLC): a California Cancer Registry analysis.
Lara MS; Brunson A; Wun T; Tomlinson B; Qi L; Cress R; Gandara DR; Kelly K
Lung Cancer; 2014 Aug; 85(2):264-9. PubMed ID: 24878033
[TBL] [Abstract][Full Text] [Related]
18. Survival difference in NSCLC and SCLC patients with diabetes mellitus according to the first-line therapy.
Nakazawa K; Kurishima K; Tamura T; Ishikawa H; Satoh H; Hizawa N
Med Oncol; 2013 Mar; 30(1):367. PubMed ID: 23307241
[TBL] [Abstract][Full Text] [Related]
19. Comparative study of clinicopathological characteristics and prognosis between combined and pure small cell lung cancer (SCLC) after surgical resection.
Guo Y; Yang L; Liu L; Wei J; Teng F; Zhang J; Zhu Y; Xing P; Li J
Thorac Cancer; 2020 Oct; 11(10):2782-2792. PubMed ID: 32779385
[TBL] [Abstract][Full Text] [Related]
20. Nomogram model for predicting cause-specific mortality in patients with stage I small-cell lung cancer: a competing risk analysis.
Li J; Zheng Q; Zhao X; Zhao J; An T; Wu M; Wang Y; Zhuo M; Zhong J; Yang X; Jia B; Chen H; Dong Z; Wang J; Chi Y; Zhai X; Wang Z
BMC Cancer; 2020 Aug; 20(1):793. PubMed ID: 32838776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]